FDA Inspection 1338520 — Kaiser Permanente Center For Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on Sep 18, 2026 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fremont, CA (United States)